Transgene
Transgene is a biopharmaceutical company that discovers and develops immunotherapeutic vaccines for the treatment of cancer.
Business Model:
Revenue: $13.9M
Employees: 51-200
Industries / Tags:
Detailed Transgene Information
Geographic Data
Address: 400 Boulevard Gonthier d’Andernach
City: Strasbourg
State: other
Zip: 67405
Country: FR
Financial Info
Stage:
post ipo equity
Raised Last:
$41M
Raised Total:$62M
Social
Metrics
6,283,005Website Global Rank
1,039Website Monthly Traffic
Twitter Followers
Description
Transgene is a biopharmaceutical company that discovers and develops immunotherapeutic vaccines for the treatment of cancer.
Contact Phone:
Contact Email:
Transgene went public on 1/12/2001 on the PA
Listed Exchange:
PA
IPO Date:
1/12/2001
Ticker Symbol:
TNG
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 5/2013 | ElsaLys Biotech | Series A | 0 |
| 5/2013 | ElsaLys Biotech | Series A | 0 |
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2017 | Private Placement | $16.7M | 1/2016 | Debt | $22.4M |
European Investment Bank |
3/2019 | Debt | $22.6M |
Natixis |
4/2019 | Post-IPO Debt | 1 | $22.4M |
Natixis Natixis Natixis Natixis |
11/2017 | Post-IPO Equity | $16.8M | 6/2021 | Post-IPO Equity | $40.7M |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
